We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Roche and Bio-Rad Enter Into Global Quality Control Partnership

By LabMedica International staff writers
Posted on 10 Mar 2021
Roche (Basel, Switzerland) and Bio-Rad Laboratories (Hercules, CA, USA) have entered into a global partnership to provide their customers access to Bio-Rad's complete line of InteliQ products and Unity QC data management solutions along with customer training and support services.

Bio-Rad offers a broad range of quality controls covering analytes for immunoassay, chemistry, cardiac assessment, immunology, diabetes, coagulation, hematology, blood gas, drugs-of-abuse, and infectious disease testing. More...
The company’s Unity QC data management solutions connect large peer groups of test systems and assay methods to the Unity Interlaboratory Program, enabling labs to compare their results in real time with over 25,000 other labs worldwide.

Through the global partnership, Roche and Bio-Rad will provide InteliQ products, a range of barcoded, load-and-go quality control tubes that provide efficiencies in workflow, in addition to Bio-Rad’s Unity QC data management solutions. The InteliQ products are designed to help streamline a lab's QC workflow with load-and-go efficiency and Unity QC data management solutions that help to reduce turnaround time and increase a laboratory’s analytical performance.

"We are proud to extend our partnership with Roche offering their customers access to our InteliQ line of quality controls and Unity QC data management solutions," said Dara Wright, Bio Rad Clinical Diagnostics Group EVP & President. "This agreement further strengthens and expands the relationship between Bio-Rad, the world’s leading QC supplier, and a leading diagnostic solutions provider."

Related Links:
Roche
Bio-Rad Laboratories



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DNA analysis of colorectal polyps can improve hereditary cancer diagnosis (Photo courtesy of Adobe Stock)

DNA Testing of Colorectal Polyps Improves Insight into Hereditary Risks

Colorectal cancer is among the most common cancers in Western countries, and hereditary factors are involved in about 5–10% of cases, particularly in younger patients. Individuals with large numbers of... Read more

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.